Jacob Alexander Sloane, M.D.
This page shows the publications co-authored by Jacob Sloane and Ursela Baber.
Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients. J Neurol. 2018 Oct; 265(10):2342-2345.
Biotin supplementation in MS clinically valuable but can alter multiple blood test results. Mult Scler. 2017 04; 23(4):619-620.
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments. Front Neurol. 2022; 13:843081.
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
Brainstem lesions are associated with sleep apnea in multiple sclerosis. Mult Scler J Exp Transl Clin. 2020 Oct-Dec; 6(4):2055217320967955.
Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis Testing. Int J MS Care. 2021 Jan-Feb; 23(1):26-30.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.